vinblastine
别名 | 29060-LE, Velban®, vincaleucoblastin, vincaleukoblastine, Velbe® |
---|---|
Compound Class | Synthetic organic |
变动原因 |
A pan tubulin inhibitor. A chemical analogue of |
Related Product | 长春花碱 |
Summary
是否批准为药物? | (FDA (1965)) |
---|---|
IUPAC Name | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide |
别名 | 29060-LE, Velban®, vincaleucoblastin, vincaleukoblastine, Velbe® |
数据库链接
DrugBank Ligand | DB00570 |
---|---|
PubChem CID | 13342 |
CAS Registry No. | 865-21-4 |
ChEMBL Ligand | CHEMBL159 |
Wikipedia | Vinblastine |
ChEBI | CHEBI:27375 |
RCSB PDB Ligand | VLB |
PEP | vinblastine |
DrugCentral Ligand | 2823 |
生物活性
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
---|---|
关联靶标 | tubulin beta class I |
临床资料
Summary of Clinical Use | Used to treat certain kinds of cancer, including Hodgkin's lymphoma, non-small cell lung cancer, breast cancer, head and neck cancer, and testicular cancer. It is also used to treat Langerhans cell histiocytosis. |
---|---|
作用机制与药效学效应 | Causes cell cycle arrest by inhibiting microtubule assembly. |
结构
Canonical SMILES | COc1cc2N(C)C3C4(c2cc1C1(CC2CN(CCc5c1[nH]c1c5cccc1)CC(C2)(O)CC)C(=O)OC)CCN1C4C(C(C3(O)C(=O)OC)OC(=O)C)(CC)C=CC1 |
---|---|
Isomeric SMILES | COc1cc2N(C)[C@@H]3[C@@]4(c2cc1[C@]1(C[C@H]2CN(CCc5c1[nH]c1c5cccc1)C[C@](C2)(O)CC)C(=O)OC)CCN1[C@H]4[C@@]([C@H]([C@]3(O)C(=O)OC)OC(=O)C)(CC)C=CC1 |
InChI | InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1 |
InChI key | JXLYSJRDGCGARV-CFWMRBGOSA-N |